These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 203419)

  • 1. 1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.
    Gertner JM; Brenton DB; Edwards RH
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():239s-244s. PubMed ID: 203419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D resistant hypophosphataemic osteomalacia: treatment with 1alpha-hydroxyvitamin D3.
    Peacock M; Heyburn PJ; Aaron JE
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():231s-237s. PubMed ID: 203418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term therapy with 1alpha-hydroxyvitamin D3 in children with 'pseudo-deficiency' rickets.
    Balsan S; Garabedian M; Courtecuisse V; Guéris J; Dommergues JP; Creignou L; le Denuff MJ; Rivron J
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():225s-230s. PubMed ID: 203417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3.
    Peacock M; Heyburn PJ; Aaron JE
    Calcif Tissue Res; 1977 May; 22 Suppl():55-62. PubMed ID: 912585
    [No Abstract]   [Full Text] [Related]  

  • 6. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteomalacia and celiac disease: response to 25-hydroxyvitamin D.
    Hepner GW; Jowsey J; Arnaud C; Gordon S; Black J; Roginsky M; Moo HF; Young JF
    Am J Med; 1978 Dec; 65(6):1015-20. PubMed ID: 742623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of siblings with familial hypophosphatemic rickets.
    Lapatsanis PD; Sbyrakis S; Megreli C; Edelstein S
    Helv Paediatr Acta; 1983 Oct; 38(4):373-81. PubMed ID: 6654689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of 1alpha-hydroxyvitamin D3 in pre-dialysis renal bone disease.
    Pierides AM; Ellis HA; Simpson W; Cook D; Kerr DN
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():109s-116s. PubMed ID: 606409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
    Carey DE; Drezner MK; Hamdan JA; Mange M; Ahmad MS; Mubarak S; Nyhan WL
    J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of senile osteoporosis with 1alpha-hydroxyvitamin D3.
    Sørensen OH; Andersen RB; Christensen MS; Friis T; Hjorth L; Jørgensen FS; Lund B; Melsen F; Mosekilde L
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():169s-175s. PubMed ID: 342143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term treatment with massive doses of 1 alpha-hydroxyvitamin D3 on calcium-phosphate balance in patients with vitamin D-dependent rickets type II.
    Takeda E; Yokota I; Saijo T; Kawakami I; Ito M; Kuroda Y
    Acta Paediatr Jpn; 1990 Feb; 32(1):39-43. PubMed ID: 2158205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3.
    Compston JE; Horton LW; Thompson RP
    Gut; 1979 Feb; 20(2):133-6. PubMed ID: 311747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varying role of vitamin D deficiency in the etiology of rickets in young children vs. adolescents in northern India.
    Balasubramanian K; Rajeswari J; Gulab ; Govil YC; Agarwal AK; Kumar A; Bhatia V
    J Trop Pediatr; 2003 Aug; 49(4):201-6. PubMed ID: 12929879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
    Seino Y; Shimotsuji T; Ishii T; Ishida M; Ikehara C; Yamaoka K; Yabuuchi H; Dokoh S
    Arch Dis Child; 1980 Jan; 55(1):49-53. PubMed ID: 6246841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to crystalline 1alpha-hydroxyvitamin D3 in vitamin D dependency.
    Reade TM; Scriver CR; Glorieux FH; Nogrady B; Delvin E; Poirier R; Holick F; DeLuca HF
    Pediatr Res; 1975 Jul; 9(7):593-9. PubMed ID: 1161348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D deficiency or resistance and hypophosphatemia.
    Sarathi V; Dhananjaya MS; Karlekar M; Lila AR
    Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101876. PubMed ID: 38365463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum parathyroid hormone concentrations in hypophosphataemic vitamin D resistant rickets.
    Fanconi A; Fischer JA; Prader A
    Helv Paediatr Acta; 1974 Aug; 29(3):187-94. PubMed ID: 4369169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.